Taiyo Now Officially Teva Unit After $934 Million Buy
This article was originally published in PharmAsia News
Executive Summary
Japan's Taiyo Pharmaceutical Industry Co. officially became the property of Israel's Teva Pharmaceutical Industries when the two companies completed the $934 million acquisition